Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$427M |
| 2 |
Roku
ROKU
|
+$393M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$345M |
| 4 |
AT&T
T
|
+$317M |
| 5 |
Qualcomm
QCOM
|
+$293M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.41B |
| 2 |
Pinduoduo
PDD
|
+$755M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$558M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.86% |
| 2 | Technology | 17.76% |
| 3 | Communication Services | 11.48% |
| 4 | Consumer Discretionary | 10.7% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Cracker Barrel
CBRL
$1.31B
| $692K | ﹤0.01% |
4,000
-62,731
| -94% | -$9.55M |
|
|
PTPI
2777
DELISTED
Petros Pharmaceuticals
PTPI
| $692K | ﹤0.01% |
742
+169
| +29% | +$159K |
|
2778
Virco
VIRC
$95.5M
| $692K | ﹤0.01% |
223,119
+11,910
| +6% | +$37.3K |
|
|
XYF
2779
X Financial
XYF
$202M
| $692K | ﹤0.01% |
186,126
+21,800
| +13% | +$68.1K |
|
|
ALJJ
2780
DELISTED
ALJ Regional Holdings Inc
ALJJ
| $690K | ﹤0.01% |
476,071
+66,351
| +16% | +$92.1K |
|
2781
Oil States International
OIS
$526M
| $688K | ﹤0.01% |
114,100
-158,086
| -58% | -$1.08M |
|
2782
INNOVATE Corp
VATE
$102M
| $688K | ﹤0.01% |
17,450
-8,310
| -32% | -$308K |
|
|
ILPT
2783
Industrial Logistics Properties Trust
ILPT
$611M
| $687K | ﹤0.01% |
29,710
-106,704
| -78% | -$2.39M |
|
2784
Invesco KBW Bank ETF
KBWB
$6.84B
| $687K | ﹤0.01% |
+11,100
| New | +$639K |
|
2785
BioCryst Pharmaceuticals
BCRX
$2.51B
| $686K | ﹤0.01% |
67,470
-1,212,910
| -95% | -$12.5M |
|
|
STAB
2786
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| $685K | ﹤0.01% |
130,551
-35,100
| -21% | -$192K |
|
|
BDSI
2787
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $685K | ﹤0.01% |
175,300
-140,600
| -45% | -$581K |
|
|
NWLI
2788
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $677K | ﹤0.01% |
2,718
-2,100
| -44% | -$451K |
|
|
ALNA
2789
DELISTED
Allena Pharmaceuticals
ALNA
| $675K | ﹤0.01% |
485,930
+238,919
| +97% | +$398K |
|
|
STRS
2790
DELISTED
STRATUS PPTYS INC
STRS
| $671K | ﹤0.01% |
22,000
+1,800
| +9% | +$48.1K |
|
2791
Core Laboratories
CLB
$571M
| $670K | ﹤0.01% |
23,289
-58,113
| -71% | -$1.99M |
|
2792
Ring Energy
REI
$349M
| $669K | ﹤0.01% |
289,800
+48,793
| +20% | +$93K |
|
2793
Covenant Logistics
CVLG
$865M
| $667K | ﹤0.01% |
64,800
+5,200
| +9% | +$46.5K |
|
2794
Galectin Therapeutics
GALT
$356M
| $666K | ﹤0.01% |
307,000
+291,373
| +1,865% | +$653K |
|
|
GHSI
2795
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
| $666K | ﹤0.01% |
+5,550
| New | +$1.12M |
|
2796
Capital Bancorp
CBNK
$617M
| $665K | ﹤0.01% |
34,449
+15,349
| +80% | +$251K |
|
|
AXDX
2797
DELISTED
Accelerate Diagnostics
AXDX
| $662K | ﹤0.01% |
7,960
-10,588
| -57% | -$1.07M |
|
|
JP
2798
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
| $661K | ﹤0.01% |
297,725
+74,900
| +34% | +$183K |
|
2799
Taylor Devices
TAYD
$172M
| $660K | ﹤0.01% |
58,208
+13,170
| +29% | +$144K |
|
|
IRD
2800
Opus Genetics
IRD
$309M
| $660K | ﹤0.01% |
113,620
+39,800
| +54% | +$370K |
|
Similar funds
Jim Simons's Q1 2021 Portfolio in Review
As of Q1 2021, Jim Simons held 3,937 positions worth $80.4B, down 13% from $92.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons withdrew a net $16B in Q1 2021, closing 676 positions and reducing 1,579 holdings. Its most notable exit was Micron Technology, an estimated $252M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Jim Simons opened a new position in Paramount Global Class B worth $255M.
- Jim Simons's largest Q1 2021 buy was Paramount Global Class B: 5,644,997 shares worth $255M.
- Jim Simons added most to Tesla in Q1 2021, an estimated $427M increase.
- Jim Simons's biggest Q1 2021 reduction was Baidu, cutting an estimated $1.41B.
- Jim Simons fully exited Micron Technology in Q1 2021, selling an estimated $252M.
- Jim Simons's ten largest holdings make up 10% of its $80.4B portfolio in Q1 2021.
- Jim Simons opened 591 new positions and closed 676 in Q1 2021.
- Jim Simons's portfolio value fell 13% quarter-over-quarter to $80.4B.
Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.